Results 241 to 250 of about 95,525 (355)

Group A Streptococcus interacts with glycosaminoglycans via M proteins to modulate bacterial adherence in vitro. [PDF]

FEBS J
McEwan TB, De Oliveira DMP, Stares EK, Hartley-Tassell LE, Day CJ, Walker MJ, Jennings MP, Sluyter R, Sanderson-Smith ML.   +8 more
europepmc   +1 more source

LIST OF RESEACH SUBJECTS OF THE BALNEOLOGICAL LABORATORY OKAYAMA UNIVERSITY [PDF]

, 1953
Oshima, Yoshio
core  

Promising Extracellular Matrix (ECM) Enzymes: Collagenase II and Chondroitinase as Non-surgical Interventions in Correcting Ear Deformities. [PDF]

Cureus
Chen C, Su X, Weng M, Lai H, Ye J, Zheng H, Wang M, Lei C.   +7 more
europepmc   +1 more source

CHONDROITIN, A NEW MUCOPOLYSACCHARIDE

Journal of Biological Chemistry, 1954
E A, DAVIDSON, K, MEYER
openaire   +2 more sources

CDG due to Defective Membrane Transporters: Update

Journal of Inherited Metabolic Disease, Volume 49, Issue 1, January 2026.
ABSTRACT Congenital disorders of glycosylation are genetic defects in the glycoprotein and glycolipid glycan assembly and attachment. Some 200 CDG have been reported since the first clinical description in 1980. Most CDG are enzymatic deficiencies, but 13 (6.5%) are defects in the ER, Golgi apparatus (GA), and plasma membrane transporters.
D. Quelhas, C. R. Ferreira, J. Jaeken
wiley   +1 more source

The Functional Epididymal Amyloid Cystatin‐Related Epididymal Spermatogenic (CRES) is a Component of the Mammalian Brain Extracellular Matrix

Journal of Neuroscience Research, Volume 104, Issue 1, January 2026.
This study investigated if the epididymal amyloid CRES (cystatin‐related epididymal spermatogenic) is present in the male and female mammalian brain. CRES is expressed by hippocampal astrocytes, CA2 and CA3 neurons, and exhibits amyloid properties in the extracellular matrix.
Alejandra Gomez, Uyen T. Tran, Petar N. Grozdanov, Gail A. Cornwall   +3 more
wiley   +1 more source

A Review of Nanoparticle‐Based Astrocyte Modulation in CNS Disorders: Evaluating the Underexplored Potential of Intranasal Delivery

Nano Select, Volume 7, Issue 1, January 2026.
Nanoparticle‐driven nose‐to‐brain drug delivery offers a noninvasive approach to bypass the blood–brain barrier (BBB) and directly modulate reactive astrocytes in CNS disorders. This review highlights biodegradable nanoparticles for astrocyte modulation, enhancing drug bioavailability, sustained release, and neuroinflammation control.
Senamile M. Dlamini, Gillian D. Mahumane, Pradeep Kumar, Yahya E. Choonara   +3 more
wiley   +1 more source

A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cells

, 2008
Michael Schwenkert, Katrin Birkholz, Michael Schwemmlein, Christian Kellner, Markus Kügler, Matthias Peipp, Dirk M. Nettelbeck, Beatrice Schuler‐Thurner, Niels Schaft, Jan Dörrie, Soldano Ferrone, Eckhart Kämpgen, Georg H. Fey   +12 more
openalex   +1 more source

Biomimetic Glycosaminoglycan-Enriched Electrospun Polymeric Scaffolds for Enhanced Early Tissue Regeneration. [PDF]

J Funct Biomater
Meyer M, Smaida R, Favreau H, Yus C, Gegout H, Arruebo M, Bahlouli N, Ladam G, Conzatti G, Lemmens S, Hua G, Fioretti F, Benkirane-Jessel N.   +12 more
europepmc   +1 more source

Evaluation of the use of animal compounds as substrates by felid fecal microbiota : a cheetah model [PDF]

, 2010
Bosch, Guido, Depauw, Sarah, Hendricks, Wouter, Hesta, Myriam, Janssens, Geert   +4 more
core